Causaly Recognized in Two Categories in the 2025 Gartner® Hype Cycle™ Report for Life Sciences R&D

Life sciences CIOs are under pressure to prove ROI on new platforms, optimize scarce resources, and maintain agility in a highly regulated environment.

Causaly’s recognition in two categories of the 2025 Gartner® Hype Cycle™ for Life Science R&D validates our role in enabling AI-native research that accelerates discovery and development.

Categories of Recognition

  • Scientific Literature Text Analytics
  • Semantic Knowledge Graph Tools

These categories represent critical capabilities for life sciences organizations, helping teams analyze research faster, uncover novel insights, support collaboration across drug discovery, translational medicine, competitive intelligence, and clinical research. Enabling R&D leaders to accelerate the path from data to decisions.

This Hype Cycle examines the suite of emerging and maturing technologies reshaping end-to-end life science R&D, from target identification and preclinical modeling to clinical trial execution. Life science CIOs must navigate an environment characterized by exponential data growth, heightened regulatory scrutiny, constrained budgets, and an accelerating shift toward precision medicine. Two critical questions CIOs and R&D leaders have to consider are:

  • How much value can an organization expect to realize from a given technology?
  • When will the technology be mature enough to reliably deliver that value?
Get complimentary access to the full Hype Cycle™ for Life Science R&D, 2025 report to help evaluate and prioritize technologies to align with your organization’s future vision and enterprise goals.

Download The 2025 Gartner® Hype Cycle™ Report

Figure1

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally. The Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates, and is used herein with permission. All rights reserved. This graphic was published by Gartner, Inc., as part of a larger research document, and should be evaluated in the context of the entire document. The Gartner document is available upon request from Causaly.

Gartner does not endorse any vendor, product, or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner, Hype Cycle Report for Life Sciences R&D, 2025, consists of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Causaly is a UK company. With Headquarters in London.